Shanghai Sanyou Medical Co Ltd (688085) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Sanyou Medical Co Ltd (688085) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥34.19 Million ≈ $5.00 Million USD) by net assets (CN¥2.10 Billion ≈ $306.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Shanghai Sanyou Medical Co Ltd for the company's overall valuation and market capitalisation.
Shanghai Sanyou Medical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Shanghai Sanyou Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Shanghai Sanyou Medical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Sanyou Medical Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Shanghai Sanyou Medical Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BYBON Group Co Ltd Class A
SHE:300736
|
-0.436x |
|
Zhejiang Jasan Holding Group Co Ltd
SHG:603558
|
0.057x |
|
Anpec Electronics
TWO:6138
|
0.041x |
|
JBG SMITH Properties
NYSE:JBGS
|
0.002x |
|
Huatian Hotel Group Co Ltd
SHE:000428
|
0.016x |
|
The Oncology Institute, Inc.
NASDAQ:STLN
|
-0.479x |
|
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
|
0.025x |
|
PT Bukalapak.com
JK:BUKA
|
0.010x |
Annual Cash Flow Conversion Efficiency for Shanghai Sanyou Medical Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Sanyou Medical Co Ltd from 2016 to 2024. View 688085 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.05 Billion ≈ $299.80 Million |
CN¥10.96 Million ≈ $1.60 Million |
0.005x | -95.91% |
| 2023-12-31 | CN¥2.04 Billion ≈ $298.91 Million |
CN¥267.43 Million ≈ $39.13 Million |
0.131x | +60.58% |
| 2022-12-31 | CN¥1.91 Billion ≈ $279.93 Million |
CN¥155.97 Million ≈ $22.82 Million |
0.082x | -2.32% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.07 Million |
CN¥144.92 Million ≈ $21.21 Million |
0.083x | +65.21% |
| 2020-12-31 | CN¥1.53 Billion ≈ $224.53 Million |
CN¥77.52 Million ≈ $11.34 Million |
0.051x | -64.16% |
| 2019-12-31 | CN¥437.81 Million ≈ $64.07 Million |
CN¥61.72 Million ≈ $9.03 Million |
0.141x | +142.41% |
| 2018-12-31 | CN¥340.24 Million ≈ $49.79 Million |
CN¥19.79 Million ≈ $2.90 Million |
0.058x | -21.95% |
| 2017-12-31 | CN¥289.06 Million ≈ $42.30 Million |
CN¥21.54 Million ≈ $3.15 Million |
0.075x | -39.21% |
| 2016-12-31 | CN¥158.19 Million ≈ $23.15 Million |
CN¥19.39 Million ≈ $2.84 Million |
0.123x | -- |
About Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more